Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer.

Chandru Gajendran, Subramanyam Janardhan Tantry, Naveen Sadhu M, Zainuddin Mohammed, Purushottam Dewang, Mahanandeesha Hallur, Sreekala Nair, Krishnakumar Vaithilingam, Basavaprabhu Nagayya, Sridharan Rajagopal, Dhanalakshmi Sivanandhan

Open source

DOI: 10.1371/journal.pone.0279063
Published: 0
Container: PLoS ONE
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0279063,
  title = {Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer.},
  author = {Chandru Gajendran and Subramanyam Janardhan Tantry and Naveen Sadhu M and Zainuddin Mohammed and Purushottam Dewang and Mahanandeesha Hallur and Sreekala Nair and Krishnakumar Vaithilingam and Basavaprabhu Nagayya and Sridharan Rajagopal and Dhanalakshmi Sivanandhan},
  year = {2023},
  journal = {PLoS ONE},
  doi = {10.1371/journal.pone.0279063},
  url = {https://doi.org/10.1371/journal.pone.0279063}
}

RIS

TY  - JOUR
TI  - Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer.
AU  - Chandru Gajendran
AU  - Subramanyam Janardhan Tantry
AU  - Naveen Sadhu M
AU  - Zainuddin Mohammed
AU  - Purushottam Dewang
AU  - Mahanandeesha Hallur
AU  - Sreekala Nair
AU  - Krishnakumar Vaithilingam
AU  - Basavaprabhu Nagayya
AU  - Sridharan Rajagopal
AU  - Dhanalakshmi Sivanandhan
PY  - 2023
JO  - PLoS ONE
DO  - 10.1371/journal.pone.0279063
UR  - https://doi.org/10.1371/journal.pone.0279063
ER  -

APA

Gajendran, C., Tantry, S. J., M, N. S., Mohammed, Z., Dewang, P., Hallur, M., Nair, S., Vaithilingam, K., Nagayya, B., Rajagopal, S., & Sivanandhan, D. (2023). Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer.. PLoS ONE. https://doi.org/10.1371/journal.pone.0279063

Source records

doaj · retrieved 2026-09-27T05:00:11.542Z